Research

Grants and Funding

Master
Content

We provide our members with support to do cutting-edge research through:

  • Introductions to collaborators from our home institutions and the wider network of HIV leading investigators
  • Identifying opportunities for funding through NIH or other funding bodies
  • Providing strategies for competitive grant applications and feedback from senior investigators on grant drafts  
  • Assistance with organizing multi-investigator grant submissions
     

For funding opportunities visit the following sites:

Heading

Featured Funding Opportunities

Content

NIDA seeks early career investigators 

PAS-21-270: AIDS-Science Track Award for Research Transition (A-START) (R03 Clinical Trial Optional)—Applications due Jan. 7, 2022

This funding opportunity announcement (FOA) seeks to facilitate the entry of both newly independent and early career investigators to the area of drug use and use disorder research and HIV/AIDS. This FOA, the AIDS-Science Track Award for Research Transition (A-START), encourages Small Research Grant (R03) applications to support research projects on drug use and/or use disorder and HIV/AIDS that can be carried out in a short period of time with limited resources. This FOA welcomes applications integrating substance use and/or substance use disorder and HIV/AIDS across all areas of research supported by NIDA.
 
Use existing data to promote substance use research

PAR-19-368: Accelerating the Pace of Drug Abuse Research Using Existing Data (R01 Clinical Trial Optional)—Applications due Jan. 7, 2022

The purpose of this funding opportunity announcement (FOA) is to invite applications proposing innovative analysis of existing social science, behavioral, administrative, and neuroimaging data to study the etiology and epidemiology of substance-using behaviors (substances defined as alcohol, tobacco, prescription, and other substances) and related disorders, prevention of substance use and HIV, and health service utilization. This FOA encourages the analyses of public use and other extant community-based or clinical datasets to their full potential in order to increase our knowledge of etiology; trajectories of substance-using behaviors and their consequences including morbidity and mortality; risk and resilience in the development of psychopathology; and strategies to guide the development, testing, implementation, and delivery of high-quality, effective, and efficient services for the prevention and treatment of substance use disorder and HIV. 
 
Support for research into HIV-associated neurological disorders (HAND)

RFA-DA-22-009: Organoid Modeling of Neural Stimulants and HIV Comorbidity of Human Brain (R01- Clinical Trial Optional)—Applications due Nov. 17, 2021

This funding opportunity announcement invites grant applications to study mechanisms underlying the neuropathophysiology of HIV-associated neurological disorders (HAND) using induced microglia and cerebral organoids generated from human-derived induced pluripotent stem cell lines. Specific emphasis is on the comorbidity of HIV and neural stimulants, including methamphetamine, amphetamine, cocaine, and nicotine, studied at the single cell and neural circuits levels.
 
Other Recent Funding Opportunities

View all NIDA funding opportunities at the intersection of HIV and substance use.